SAROJA Stock Overview
Trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Saroja Pharma Industries India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹55.85 |
| 52 Week High | ₹70.75 |
| 52 Week Low | ₹33.10 |
| Beta | 0 |
| 1 Month Change | -3.62% |
| 3 Month Change | -4.28% |
| 1 Year Change | 0.63% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -18.17% |
Recent News & Updates
Shareholder Returns
| SAROJA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -0.2% | -0.2% | -2.1% |
| 1Y | 0.6% | 44.5% | 22.5% |
Return vs Industry: SAROJA underperformed the Indian Healthcare industry which returned 46.5% over the past year.
Return vs Market: SAROJA underperformed the Indian Market which returned 24.7% over the past year.
Price Volatility
| SAROJA volatility | |
|---|---|
| SAROJA Average Weekly Movement | 9.3% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: SAROJA's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: SAROJA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 16 | Biju Nair | www.sarojapharma.com |
Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, Europe, and internationally. The company’s products are used in human, veterinary, and pharmaceutical products. Saroja Pharma Industries India Limited was incorporated in 2019 and is based in Mumbai, India.
Saroja Pharma Industries India Limited Fundamentals Summary
| SAROJA fundamental statistics | |
|---|---|
| Market cap | ₹224.54m |
| Earnings (TTM) | ₹7.12m |
| Revenue (TTM) | ₹382.75m |
31.5x
P/E Ratio0.6x
P/S RatioIs SAROJA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAROJA income statement (TTM) | |
|---|---|
| Revenue | ₹382.75m |
| Cost of Revenue | ₹333.84m |
| Gross Profit | ₹48.91m |
| Other Expenses | ₹41.79m |
| Earnings | ₹7.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.77 |
| Gross Margin | 12.78% |
| Net Profit Margin | 1.86% |
| Debt/Equity Ratio | 58.4% |
How did SAROJA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 10:38 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Saroja Pharma Industries India Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|